Study

EORTC-55981

A randomized trial of Paclitaxel/Epirubicin/Carboplatin Combination (TEC) versus Paclitaxel/Carboplatin (TC) in the treatment of women with Advanced Ovarian Cancer

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 27-Aug-1999
Date Step1 close: 15-Oct-2001

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 800

Protocol summary

http://clinicaltrials.gov/study/NCT00004934

NCT number

NCT00004934